Substance / Medication

Tositumomab

Overview

Active Ingredient
tositumomab
RxNorm CUI
263010

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.
Wahl Richard L, Horner Thierry J, Lin Thomas S et al. · J Nucl Med · 2015
PMID: 26338897Observational
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission.
Buchegger Franz, Antonescu Cristian, Helg Claudine et al. · J Nucl Med · 2011
PMID: 21571800Observational
Comparison of medium- and high-energy collimators for 131I-tositumomab dosimetry.
Mah Eugene, Spicer Ken M · J Nucl Med Technol · 2007
PMID: 17823454Observational
Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice.
Jacene Heather A, Filice Ross, Kasecamp Wayne et al. · J Nucl Med · 2007
PMID: 17942813Observational
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.
Dosik Alan D, Coleman Morton, Kostakoglu Lale et al. · Cancer · 2006
PMID: 16362977Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tositumomab (substance)
SNOMED CT
407318006
UMLS CUI
C0879399
RxNorm CUI
263010

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.